Potential Immune-Inflammatory Proteome Biomarkers for Guiding the Treatment of Patients with Primary Acute Angle-Closure Glaucoma Caused by COVID-19.

MLA

Gong, Qiaoyun, et al. “Potential Immune-Inflammatory Proteome Biomarkers for Guiding the Treatment of Patients with Primary Acute Angle-Closure Glaucoma Caused by COVID-19.” Journal of Proteome Research, vol. 23, no. 7, July 2024, pp. 2587–97. EBSCOhost, https://doi.org/10.1021/acs.jproteome.4c00325.

APA

Gong, Q., Fu, M., Wang, J., Zhao, S., & Wang, H. (2024). Potential Immune-Inflammatory Proteome Biomarkers for Guiding the Treatment of Patients with Primary Acute Angle-Closure Glaucoma Caused by COVID-19. Journal of Proteome Research, 23(7), 2587–2597. https://doi.org/10.1021/acs.jproteome.4c00325

Chicago

Gong, Qiaoyun, Mingshui Fu, Jingyi Wang, Shuzhi Zhao, and Haiyan Wang. 2024. “Potential Immune-Inflammatory Proteome Biomarkers for Guiding the Treatment of Patients with Primary Acute Angle-Closure Glaucoma Caused by COVID-19.” Journal of Proteome Research 23 (7): 2587–97. doi:10.1021/acs.jproteome.4c00325.